New Zealand markets closed

Labcorp Holdings Inc. (LH)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
210.59-2.54 (-1.19%)
At close: 04:00PM EDT
210.49 -0.10 (-0.05%)
After hours: 07:51PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close213.13
Open213.52
Bid198.01 x 1100
Ask217.00 x 800
Day's range208.19 - 213.52
52-week range179.59 - 234.09
Volume730,351
Avg. volume789,580
Market cap17.751B
Beta (5Y monthly)1.01
PE ratio (TTM)45.00
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield2.88 (1.37%)
Ex-dividend date28 May 2024
1y target estN/A
  • PR Newswire

    Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of its first trimester preeclampsia screening test to be performed between 11 and 14 weeks gestation to determine the risk of developing preeclampsia before 34 weeks of pregnancy. It is the only test of its kind available in the United States and is relevant for all pregnant individuals, including those with a low- to average-risk for preeclampsia or first-time pregnancies.

  • PR Newswire

    Labcorp to Webcast Its Annual Meeting of Shareholders

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be webcast live on May 14 at 9:00 a.m. ET and can be viewed online on the Labcorp Investor Relations website. An archived replay of the webcast will be available for one year.

  • PR Newswire

    Invitae Receives Court Approval for Sale to Labcorp

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae (OTC:NVTAQ), a leading medical genetics company, announced today that the United States Bankruptcy Court has approved the previously announced bid by Labcorp to acquire assets of Invitae.